COVID-19 Vaccination Efficacy and Safety Literature Review
Journal Title: Journal of Clinical and Medical Research - Year 2021, Vol 3, Issue 1
Abstract
Since the emergency of the novel coronavirus disease (COVID-19) that is caused by SARS-Cov-2 in 2019, researchers have been on the move to find solutions to mitigate the spread of the virus. Various control measures have been put in place by governments under guidelines and recommendations of key global agencies with the world health organization (WHO) leading in providing information to help fight the pandemic. Multi-agency research efforts have been geared towards developing vaccines for active immunization to prevent COVID-19 infection. This paper is geared towards providing a detailed review and analysis of developments of the current vaccines in terms of safety and efficacy. Approaches that have been taken by different researchers and their findings are the subject of this work. Based on the mechanism by which a vaccine protects an individual against COVID-19 infection, it has been found that the already rolled out vaccines are mRNA (Pfizer and Moderna) and vector (Astrazeneca) vaccine structured. There is also China's Sinovac vaccine which has been in place for the past few years. The four vaccines reviewed here are administered in two doses some days apart. Currently, no vaccine has a safety threat and the efficacies are 95% for COVID-19 mRNA vaccine BNT162b2 (Pfizer), 94.1% for mRNA-1273 vaccine (Moderna), 70.4%forChAdOx1 nCoV-19 vaccine / AZD1222 (AstraZeneca) vaccine and 78% for sinovac respectively. Findings of this paper show that other vaccines are awaiting clinical roll out for trials. Even though these efficacies imply that the vaccines offer significant protection against the infection, further research and evaluation should go on to achieve higher efficacies while addressing any safety concerns that may go beyond local and systemic reactions that occur on patients after vaccination. This study concludes that even with the protection of the present vaccines, individuals must continue wearing personal protective equipment (PPEs) such as masks.
Authors and Affiliations
Michael Halim1*, Alice Halim2and Yovita Tjhin
Keywords
Related Articles
- EP ID EP708417
- DOI https://doi.org/10.37191/Mapsci-2582-4333-3(1)-058
- Views 89
- Downloads 0
Connection Between Indications of Binocular Single Vision Anomalies and Punctum Proximum Among University Students of India
Purpose: To evaluate the connection between indications of binocular single vision anomalies and punctum proximum among university students of India. Method: This was a cross-sectional prospective study of 90 randomly...
COVID-19 Vaccination Efficacy and Safety Literature Review
Since the emergency of the novel coronavirus disease (COVID-19) that is caused by SARS-Cov-2 in 2019, researchers have been on the move to find solutions to mitigate the spread of the virus. Various control measures have...
Presence of Proteins in 17% EDTA after Contact with the Bovine Dentine
EDTA 17% is a solution frequently used in endodontics for the extraction of the mineralized remains of dentine from the root canals. Its chelating action could affect the dentine making it susceptible to insults. The obj...
Crossroad of Molecular Networks and Disease Treatment
Various molecular networks including both canonical and non-canonical pathways are activated in cancer. It has some rationales to target the molecular network pathways to treat cancer, considering that the pathway regula...
Clinical Study Start-Up: Overview of the Process and Expected Challenges
Start-up phase is the base of any project at any type of business, and CROs are not an exception. Initially, the emphasis was concentrated on conducting the study, with little attention paid to study start-ups (SSUs), bu...